3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Colorectal Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Lung Neoplasms
12
Head and Neck Neoplasms
10
Rectal Neoplasms
8
Prostatic Neoplasms
7
Mouth Neoplasms
5
Glioblastoma
5
Esophageal Neoplasms
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Ovarian Neoplasms
3
Neuroblastoma
3
Neoplasms
3
Laryngeal Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Turcot syndrome
2
Tongue Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Interventions
Temozolomide
2
Sirolimus
2
Irinotecan
2
Bevacizumab
2
tozuleristide
1
etoposide phosphate
1
Stem Cell Transplantation
1
Pregabalin
1
Nivolumab
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Levetiracetam
1
Immunoglobulin G
1
Ginkgo biloba extract
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pinealoma
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled